As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

To avoid a tug-of-war between scientific rigour and operational efficiency, we must focus on the user and data journeys of ...

Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines mark a significant milestone in breast cancer treatment, seamlessly integrating cutting-edge international research with Chinese ...

A Manchester medtech company has secured new funding to continue scaling its reusable digital device that can track whether ...

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

Anavex Life Sciences Corp. (NASDAQ ... 2b/3ATTENTION-AD open-label extension trial. The data demonstrated that over three ...

MMS, a Canton Township-based clinical research organization, has acquired Exploristics, a biostatistics and data science company based in Belfast, Northern Ireland. Terms of the transaction were not ...

By creating a new metric, researchers envision the possibility of diagnostic and treatment advances for the disease, which is estimated to affect about 4 million people worldwide.

According to the scientists, study participants had fewer days to recover from the illnesses when compared to the standard of ...

Providers are breaking down data silos and improving interoperability to open up pathways for critical insights.